NCT01083589
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Non-small Cell Lung Cancer
Explore clinical trials studying Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.
1,362 public trials
335 recruiting studies
Non-small Cell Lung Cancer trial results
NCT01065415
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Samsung Medical Center Seoul, South Korea
NCT01494558
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
Not specified
NCT00191308
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +11 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bystra, Poland
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Poznan, Poland
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Warsaw, Poland
NCT00085826
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Birmingham Hematology Oncology Associates Birmingham, Alabama, United States
- Birmingham Hematology and Oncology Associates, LLC Birmingham, Alabama, United States
- Northern Arizona Hematology and Oncology Associates Flagstaff, Arizona, United States
- Hematology & Oncology Associates Phoenix, Arizona, United States
NCT00356122
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +14 more
- Locations
-
- Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States
Completed
Observations From Long Term Responders in the Gefitinib (Iressa) Expanded Access Program (EAP)
NCT01103089
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Research Site Amsterdam, Netherlands
- Research Site Apeldoorn, Netherlands
- Research Site Groningen, Netherlands
- Research Site Helmond, Netherlands
Completed
NovoTTF-100L in Combination With Pemetrexed (Alimta®) for Advanced Non-small Cell Lung Cancer
NCT00749346
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
- CCRC Basel, Switzerland
- Kantonspital Graubunden Chur, Switzerland
- Kantonspital Fribourg Fribourg, Switzerland
- Kantonspital Winterthur Winterthur, Switzerland
NCT01112631
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- M. Sklodowska-Curie Memorial Cancer Centre Warsaw, Poland
NCT00881296
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Hamamatsu University School of Medicine Hamamatsu, Shizuoka, Japan